97 related articles for article (PubMed ID: 377082)
21. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease.
Pomara N; Domino EF; Yoon H; Brinkman S; Tamminga CA; Gershon S
J Clin Psychiatry; 1983 Aug; 44(8):293-5. PubMed ID: 6874650
[TBL] [Abstract][Full Text] [Related]
22. Phosphatidylserine in the treatment of Alzheimer's disease: results of a multicenter study.
Amaducci L
Psychopharmacol Bull; 1988; 24(1):130-4. PubMed ID: 3290936
[No Abstract] [Full Text] [Related]
23. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D
Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
[No Abstract] [Full Text] [Related]
24. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment.
Golden R
Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576
[TBL] [Abstract][Full Text] [Related]
25. Choline in Alzheimers disease.
Levy R
Lancet; 1978 Oct; 2(8096):944-5. PubMed ID: 81959
[No Abstract] [Full Text] [Related]
26. A neuropsychological test battery for use in Alzheimer disease clinical trials.
Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
[TBL] [Abstract][Full Text] [Related]
27. Effects of 4-aminopyridine in elderly patients with Alzheimer's disease.
Wesseling H; Agoston S; Van Dam GB; Pasma J; DeWit DJ; Havinga H
N Engl J Med; 1984 Apr; 310(15):988-9. PubMed ID: 6366565
[No Abstract] [Full Text] [Related]
28. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
29. Cholinergic precursors in Alzheimer's disease.
Pomara N; Stanley M
Lancet; 1982 Nov; 2(8306):1049. PubMed ID: 6127534
[No Abstract] [Full Text] [Related]
30. A pilot study of serotonergic system responsivity in Alzheimer's disease.
Lawlor BA; Mellow AM; Sunderland T; Hill JL; Murphy DL
Psychopharmacol Bull; 1988; 24(1):127-9. PubMed ID: 3290935
[No Abstract] [Full Text] [Related]
31. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
Grossmann W; Standl A; May U
Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
[No Abstract] [Full Text] [Related]
32. Choline chloride fails to improve cognition of Alzheimer's disease.
Thal LJ; Rosen W; Sharpless NS; Crystal H
Neurobiol Aging; 1981; 2(3):205-8. PubMed ID: 7312098
[TBL] [Abstract][Full Text] [Related]
33. Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.
N Engl J Med; 1983 Sep; 309(9):555-6. PubMed ID: 6877328
[No Abstract] [Full Text] [Related]
34. Low- and high-dose naloxone in dementia of the Alzheimer type.
Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
[No Abstract] [Full Text] [Related]
35. Treatment of Alzheimer's disease: a cautionary note.
Bowen DM; Sims NR; Benton JS; Curzon G; Davison AN; Neary D; Thomas DJ
N Engl J Med; 1981 Oct; 305(17):1016. PubMed ID: 7278915
[No Abstract] [Full Text] [Related]
36. Clinical effects of choline in Alzheimer senile dementia.
Boyd WD; Graham-White J; Blackwood G; Glen I; McQueen J
Lancet; 1977 Oct; 2(8040):711. PubMed ID: 71516
[No Abstract] [Full Text] [Related]
37. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
38. Multicenter trial of naloxone in Alzheimer's disease.
Henderson VW; Roberts E; Wimer C; Bardolph EL; Chui HC; Damasio AR; Eslinger PJ; Folstein MF; Schneider LS; Teng EL
Ann Neurol; 1989 Apr; 25(4):404-6. PubMed ID: 2653175
[TBL] [Abstract][Full Text] [Related]
39. Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease.
Fisman M; Mersky H; Helmes E
Am J Psychiatry; 1981 Jul; 138(7):970-2. PubMed ID: 7020434
[TBL] [Abstract][Full Text] [Related]
40. Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease.
Levy R; Little A; Chuaqui P; Reith M
Lancet; 1983 Apr; 1(8331):987-8. PubMed ID: 6132292
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
